USCDI Export for the Public
| Classification Level Sort descending | Data Class | Data Class Description | Data Element | Data Element Description | Applicable Standards | Submitter Name | Submitter Organization | Submission Date |
|---|---|---|---|---|---|---|---|---|
| Draft USCDI V4 | Activity performed for or on a patient as part of the provision of care. |
Activity performed for or on a patient as part of the provision of care. |
Optional:
|
|||||
| Draft USCDI V4 | The metadata, or extra information about data, regarding who created the data and when it was created. |
Date and time of author action. |
||||||
| Draft USCDI V4 | The metadata, or extra information about data, regarding who created the data and when it was created. |
Organization associated with author. |
||||||
| Draft USCDI V4 | Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s authorized representative, or patient’s healthcare provider that could identify a need, problem, or condition. |
Assessment of a patient’s smoking behaviors. |
|
|||||
| Draft USCDI V4 | Instrument, machine, appliance, implant, software, or similar device intended to be used for a medical purpose. |
Numeric or alphanumeric code that uniquely identifies an implantable device. Usage note: Contains a Device Identifier (DI) and one or more Production Identifiers (PI). |
|
Marti Velezis | FDA/CDRH/Indira Konduri (FDA/CDRH/OPEQ/ORP/DRPIII) | |||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required.
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required.
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required
|
||||||
| Draft USCDI V4 | Physiologic measurements of a patient that indicate the status of the body’s life sustaining functions. |
Both standards are required
|
||||||
| Draft USCDI V4 | Harmful or undesired physiological responses associated with exposure to a substance. |
Pharmacologic agent believed to cause a harmful or undesired physiologic response following exposure. |
|
|||||
| Draft USCDI V4 | Harmful or undesired physiological responses associated with exposure to a substance. |
Pharmacologic category for an agent believed to cause a harmful or undesired physiologic response following exposure. |
|
|||||
| Draft USCDI V4 | Harmful or undesired physiological responses associated with exposure to a substance. |
Harmful or undesired physiologic response following exposure to a pharmacologic agent or class of agents. |
|